Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health
Authors:
- Eugenio CaradonnaECEugenio Caradonna
- Federico AbateFAFederico Abate
- Elisabetta SchianoElisabetta Schiano
- Francesca PaparellaFPFrancesca Paparella
- Fulvio FerraraFulvio Ferrara
- Emilio VanoliEVEmilio Vanoli
- Rossana DifruscoloRDRossana Difruscolo
- Vito Maria GoffredoVGVito Maria Goffredo
- Bruno AmatoBABruno Amato
- Carlo SetacciCarlo Setacci
- Francesco SetacciFSFrancesco Setacci
- Ettore NovellinoENEttore Novellino
Top Cited Papers
Open Access
- 24 March 2025
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 15 (4) , 220
Abstract
The intestinal microbiota, hosting trillions of microorganisms that inhabit the gastrointestinal tract, functions as a symbiotic organism that plays a crucial role in regulating health by producing biologically active molecules that can enter systemic circulation. Among them, trimethylamine-N-oxide (TMAO), an organic compound derived from dietary sources and microbial metabolism, has emerged as a critical biomarker linking diet, the gut microbiota, and the host metabolism to various pathological conditions. This comprehensive review highlights TMAO’s biosynthesis, physiological functions, and clinical significance, focusing on its mechanistic contributions to cardiovascular and neurodegenerative diseases. Notably, TMAO-mediated pathways include endothelial dysfunction, inflammation via NLRP3 inflammasome activation, and cholesterol metabolism disruption, which collectively accelerate atherosclerosis and disease progression. Nonetheless, this work underscores the innovative potential of targeting TMAO through dietary, nutraceutical, and microbiota-modulating strategies to mitigate its pathological effects, marking a transformative approach in the prevention and management of TMAO-related disorders.Keywords
This publication has 171 references indexed in Scilit:
- Circulating trimethylamine N-oxide levels following fish or seafood consumptionEuropean Journal of Nutrition, 2022
- Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population studyAmerican Heart Journal, 2021
- The Gut Metabolite Trimethylamine N‐oxide Is Associated With Parkinson's Disease Severity and ProgressionMovement Disorders, 2020
- The gut microbiome–derived metabolite trimethylamine N-oxide modulates neuroinflammation and cognitive function with agingGeroScience, 2020
- Gut Microbiota and the Metabolism of PhytoestrogensRevista Brasileira de Farmacognosia, 2020
- Association with Outcomes and Response to Treatment of Trimethylamine N-Oxide in Heart Failure: Results from BIOSTAT-CHFEuropean Journal of Heart Failure, 2018
- Probiotic supplementation and trimethylamine‐N‐oxide production following a high‐fat dietObesity, 2015
- Novel approaches to the post-myocardial infarction/heart failure neural remodelingHeart Failure Reviews, 2013
- Functional characterization of genetic variants of human FMO3 associated with trimethylaminuriaArchives of Biochemistry and Biophysics, 2007
- Glycine metabolism in anaerobesAntonie van Leeuwenhoek, 1994